Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mental Health and Academic Performance in COVID-19 (PANDEMIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04420416
Recruitment Status : Recruiting
First Posted : June 9, 2020
Last Update Posted : July 28, 2020
Sponsor:
Information provided by (Responsible Party):
GONZALEZ-OJEDA ALEJANDRO, Instituto Mexicano del Seguro Social

Brief Summary:
This study aims to identify the preference of the class modalities (classroom or online) in undergraduate and graduate students. Additionally, to explore if the presence of any mental state alterations such as depression or anxiety due to the COVID-19 pandemic can alter their perception of academic performance.

Condition or disease Intervention/treatment
Depression, Anxiety Other: Survey

Layout table for study information
Study Type : Observational
Estimated Enrollment : 720 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: dePression, Anxiety, aNd acaDemic pErforMance In Covid-19: PANDEMIC Study.
Actual Study Start Date : April 1, 2020
Estimated Primary Completion Date : July 30, 2020
Estimated Study Completion Date : July 30, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety


Intervention Details:
  • Other: Survey
    The investigators will use the Spanish language validated version of the Academic Self-Concept Scale (ASCS), the Patient Health Questionnaire-9 (PHQ-9) depression screening scale, and the General Anxiety Disorder-7 (GAD-7) screening scale. Additionally, the sample will be asked about their gender, age, preference of teaching modality, and finally, if the participants have perceived a change in their performance or any change in their grades.


Primary Outcome Measures :
  1. Academic Self-Concept Scale Score [ Time Frame: up to 3 months ]
    This scale will explore the effort and confidence of the participants. The minimum score for each facet is 10, and the maximum score is 70.

  2. PHQ-9 Score [ Time Frame: up to 3 months ]
    This inventory will be used to identify the presence and intensity of depressive disorders. The minimum score is 0, and the maximum score is 27.

  3. GAD-7 Score [ Time Frame: up to 3 months ]
    This questionnaire will be used to evaluate the presence and intensity of anxiety disorders. The minimum score is 0, and the maximum score is 21.

  4. Preference of teaching method [ Time Frame: up to 3 months ]
    Students' preference of classroom or online classes.

  5. Self perceived academic performance [ Time Frame: up to 3 months ]
    Students' perception of changes in their academic performance: got better, worse, or stayed the same.

  6. Academic grades changes [ Time Frame: up to 3 months ]
    Students' perception of changes in their grades: got better, worse, or stayed the same.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Undergraduate and graduate students who attend an online university course.
Criteria

Inclusion Criteria:

  • > 18 years
  • Students of any undergraduate or graduate course who are attending their semester online

Exclusion Criteria:

  • Students who are not attending an online course
  • Students who are not registered in a university undergraduate or graduate course.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04420416


Locations
Layout table for location information
Mexico
Instituto Mexicano del Seguro Social Recruiting
Guadalajara, Jalisco, Mexico, 44329
Contact: Alejandro Gonzalez Ojeda, PhD    +52333170060 ext 31309    avygail5@gmail.com   
Sponsors and Collaborators
Instituto Mexicano del Seguro Social
Layout table for additonal information
Responsible Party: GONZALEZ-OJEDA ALEJANDRO, Investigador Titular D, Instituto Mexicano del Seguro Social
ClinicalTrials.gov Identifier: NCT04420416    
Other Study ID Numbers: Mental01
First Posted: June 9, 2020    Key Record Dates
Last Update Posted: July 28, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is no plan of making individual participant data available.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by GONZALEZ-OJEDA ALEJANDRO, Instituto Mexicano del Seguro Social:
COVID-19
Depression
Anxiety
Public health
Academic performance
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Depressive Disorder
Anxiety Disorders
Behavioral Symptoms
Mood Disorders
Mental Disorders